Partnering with GSK

How we engage

• By collaborating with outstanding scientists at academic institutions to accelerate discovery and development of new vaccines and medicines
• Through licensing advanced technology and potential vaccines and medicines from biotech companies
• Establishing joint ventures to strengthen innovation and improve efficiency

Why this matters

• Finding the right partner helps to identify and accelerate a potential vaccine or medicine to reach the patients that need it
• It allows us to push the science and technology as far as it can go to impact human health
• We can collectively share and advance our scientific knowledge

What we’re doing

• Working with world-leading experts at biotech companies, research institutes and universities to improve drug and vaccine discovery to increase the productivity of our R&D pipeline
• Collaborating with a broad range of partners to support our R&D focus on the science of the immune system, human genetics and advanced technologies
• Supporting the advancement of scientific knowledge with our long-standing commitment to sharing research